Dietary antioxidant quercetin overcomes the acquired resistance of Sorafenib in Sorafenib-resistant hepatocellular carcinoma cells through epidermal growth factor receptor signaling inactivation
- Reference:
- Naunyn-Schmiedeberg's Archives of Pharmacology
- 2024
- 397
- 559–574
- DOI:
- 10.1007/s00210-023-02605-3